Nurse Practitioner, Family · Kouts, IN
NPI
1265957971
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
703 N Main St
Kouts, IN, 46347
Phone (219) 766-3131
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
852 services
Medicare patients, 2024
363
Average age 74
Drug cost, 2024
$566K
643 prescriptions
Company payments, 2025
$2,333
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelly R Hardesty was code 99232 (hospital e&m - subsequent), 295 times for 123 patients. In total Kelly R Hardesty billed 852 services in 12 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 295 | 123 | $48.09 | $14K |
| 99213 Office E&M - Established | Office | 257 | 174 | $56.06 | $14K |
| 99214 Office E&M - Established | Office | 192 | 120 | $76.20 | $15K |
| 99204 Office E&M - New | Office | 55 | 55 | $89.34 | $4,914 |
| 99212 Office E&M - Established | Office | 24 | 20 | $29.32 | $704 |
By year: 2022 $47K for 684 services; 2023 $44K for 687 services; 2024 $50K for 852 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kelly R Hardesty prescribed most often to Medicare patients was Cephalexin, with 67 prescriptions and refills. In total Kelly R Hardesty wrote 643 Medicare prescriptions that cost $566K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 67 | 109 | 39 | $789 |
| Doxycycline Monohydrate Generic | 60 | 84 | 38 | $1,426 |
| Daptomycin Generic | 47 | 47 | Under 11 | $100K |
| Fosfomycin Tromethamine Generic | 40 | 55 | 14 | $12K |
| Nuzyra Omadacycline Tosylate | 37 | 37 | 18 | $355K |
| Doxycycline Hyclate Generic | 35 | 50 | 28 | $540 |
| Levofloxacin Generic | 34 | 34 | 22 | $152 |
| Cefdinir Generic | 32 | 44 | 17 | $513 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 28 | 29 | 20 | $329 |
| Meropenem Generic | 27 | 27 | Under 11 | $9,835 |
| Cefazolin Sodium Generic | 26 | 26 | Under 11 | $538 |
| Fluconazole Generic | 24 | 32 | 14 | $173 |
| Amoxicillin Generic | 18 | 23 | 12 | $59.41 |
| Ertapenem Ertapenem Sodium | 16 | 16 | Under 11 | $19K |
| Cefepime Hcl Generic | 15 | 15 | Under 11 | $4,941 |
Brand drugs: 81 claims; generic drugs: 562 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelly R Hardesty $2,333 ($2,333 in general payments such as food, travel and fees) from 9 companies. The largest payer was Paratek Pharmaceuticals, Inc. with $607.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.